Larimar Therapeutics (LRMR)
(Delayed Data from NSDQ)
$7.24 USD
-0.24 (-3.21%)
Updated Sep 12, 2024 03:59 PM ET
After-Market: $7.26 +0.02 (0.28%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/12/2024
Time: -- |
9/2024 | $-0.37 | 0.00% |
Earnings Summary
For their last quarter, Larimar Therapeutics (LRMR) reported earnings of -$0.34 per share, missing the Zacks Consensus Estimate of -$0.32 per share. This reflects a negative earnings surprise of 6.25%. Look out for LRMR's next earnings release expected on November 12, 2024. For the next earning release, we expect the company to report earnings of -$0.37 per share, reflecting a year-over-year decrease of 76.19%.
Earnings History
Price & Consensus
Zacks News for LRMR
Biotech Stock Roundup: BIIB's Acquisition, PTCT, LRMR Gain on Updates & More News
LRMR: What are Zacks experts saying now?
Zacks Private Portfolio Services